RAPGEF3 and heart disorder: Accumulating evidence now suggests that downstream cAMP effectors such as PKA and Epac as well as Ca2+ signalling including CaMKII modulate a variety of fundamental cellular processes involved in fibroblasts and fibrosis‐associated cardiac diseases.74, 75, 76